R.K. Rao et al. / Tetrahedron 65 (2009) 4619–4624
4623
125.3,127.0,129.2,129.9,131.1,134.8,139.5; MS (EI, m/z) 272 [MH]þ;
J¼3.6 Hz, 1H), 7.07–7.17 (m, 2H), 7.24 (d, J¼3.2 Hz, 1H), 7.47 (d,
J¼8.4 Hz, 2H), 7.52 (d, J¼8.0 Hz, 1H), 7.58 (d, J¼7.6 Hz, 1H), 7.98 (d,
HRMS [MH]þ calculated for C14H11NBr 272.0075, found 272.0080.
J¼8.4 Hz, 2H); 13C NMR (100 MHz, CDCl3)
d 26.6, 105.2, 110.7, 121.2,
4.6. 5-Methoxy-1-phenyl-1H-indole (Table 3, entry 5)15
121.5, 123.0, 123.4, 127.4, 130.0, 130.1, 134.8, 135.6, 143.9, 196.7; MS
(EI, m/z) 236 [MH]þ; HRMS [MH]þ calculated for C16H14NO
236.1075, found 236.1067.
Colorless liquid; Rf 0.78 (1:9 ethyl acetate/hexanes); FTIR (neat)
2931, 2835, 1594, 1487, 1463, 1444, 1254, 1151, 799, 754, 705 cmꢁ1
;
1H NMR (400 MHz, CDCl3)
(dd, J¼2.4, 8.8 Hz, 1H), 7.20 (d, J¼2.4 Hz, 1H), 7.35–7.38 (m, 2H),
7.51–7.54 (m, 5H); 13C NMR (100 MHz, CDCl3)
56.0, 102.9, 103.4,
d
3.92 (s, 3H), 6.66 (d, J¼2.8 Hz, 1H), 6.94
4.12. 1-(3,5-Dimethylphenyl)-1H-indole (Table 3, entry 11)18
d
Colorless liquid; Rf 0.50 (hexanes); FTIR (neat) 3046, 2921, 2854,
111.5, 112.6, 124.2, 126.4, 128.5, 129.7, 130.0, 131.2, 140.1, 154.7; MS
(EI, m/z) 224 [MH]þ; HRMS [MH]þ calculated for C15H14NO
224.1075, found 224.1072.
1599, 1467, 1208, 732, 705 cmꢁ1 1H NMR (400 MHz, CDCl3)
; d 2.28
(s, 6H), 6.55 (d, J¼3.2 Hz, 1H), 6.88 (s, 1H), 7.01–7.11 (m, 4H), 7.20 (d,
J¼3.2 Hz, 1H), 7.46 (d, J¼8.4 Hz, 1H), 7.57 (d, J¼7.6 Hz, 1H); 13C NMR
(100 MHz, CDCl3) d 21.5, 103.3, 110.8,120.3, 121.2, 122.2, 122.3, 128.1,
4.7. 1-(1-Phenyl-1H-indol-3-yl)-ethanone (Table 3, entry 6)15
128.2, 129.4, 136.0, 139.5, 139.8; MS (EI, m/z) 222 [MH]þ; HRMS
[MH]þ calculated for C16H16N 222.1283, found 222.1287.
Colorless solid, mp 143–145 ꢀC (lit.15 145 ꢀC); Rf 0.48 (1:1 ethyl
acetate/hexanes); FTIR (neat) 3096, 3045, 1639, 1595, 1530, 1494,
4.13. Methyl 4-(1-(3-methoxyphenyl)-1H-indol-3-yl)-
butanoate (Table 3, entry 12)
1223, 748, 693 cmꢁ1
;
1H NMR (400 MHz, CDCl3)
d
2.59 (s, 3H),
7.28–7.37 (m, 2H), 7.45–7.49 (m, 2H), 7.52–7.60 (m, 4H), 7.94 (s, 1H),
8.45–8.47 (m, 1H); 13C NMR (100 MHz, CDCl3)
27.9, 110.9, 118.8,
d
Colorless viscous liquid; Rf 0.45 (1:9 ethyl acetate/hexanes); FTIR
122.9, 123.3, 124.1, 125.1, 126.7, 128.2, 130.1, 134.8, 137.2, 138.6,
193.5; MS (EI, m/z) 258 [MNa]þ; HRMS [MH]þ calculated for
C16H14NO 236.1075, found 236.1074.
(neat) 2948, 2848, 1732, 1594, 1492, 1460, 1204, 1176, 1044, 779,
740, 694 cmꢁ1 1H NMR (400 MHz, CDCl3)
; d 2.10 (m, 2H), 2.44 (t,
J¼7.4 Hz, 2H), 2.86 (t, J¼7.6 Hz, 2H), 3.67 (s, 3H), 3.87 (s, 3H),
6.86–6.89 (m, 1H), 7.03–7.04 (m, 1H), 7.07–7.09 (m, 1H), 7.15–7.24
(m, 3H), 7.4 (t, J¼8.0 Hz,1H), 7.59 (d, J¼8.4 Hz,1H), 7.64 (d, J¼8.0 Hz,
4.8. 1-p-Tolyl-1H-indole (Table 3, entry 7)3b
1H); 13C NMR (100 MHz, CDCl3)
d 24.6, 25.4, 33.9, 51.6, 55.6, 110.1,
Colorless liquid; Rf 0.67 (1:19 ethyl acetate/hexanes); FTIR (neat)
110.8, 111.8, 116.5, 116.9, 119.4, 120.1, 122.6, 125.4, 129.2, 130.4, 136.3,
141.2, 160.8, 174.2; MS (EI, m/z) 346 [MNa]þ; HRMS [MNa]þ calcu-
lated for C20H21NO3Na 346.1419, found 346.1419.
3039, 2921, 1514, 1454, 1329, 730 cmꢁ1; 1H NMR (400 MHz, CDCl3)
d
2.34 (s, 3H), 6.57 (d, J¼2.8 Hz,1H), 7.05–7.14 (m, 2H), 7.20–7.22 (m,
3H), 7.29 (d, J¼8.0 Hz, 2H), 7.44 (d, J¼8.0 Hz, 1H), 7.59 (d, J¼7.6 Hz,
1H); 13C NMR (100 MHz, CDCl3)
21.2, 103.3, 110.6, 120.3, 121.2,
d
4.14. 1-(3-Nitrophenyl)-1H-indole (Table 3, entry 13)19
122.3, 124.5, 128.2, 129.3, 130.3, 136.2, 136.4, 137.4; MS (EI, m/z) 208
[MH]þ; HRMS [MH]þ calculated for C15H14N 208.1126, found
208.1124.
Pale yellow solid, mp 66–68 ꢀC (lit.19 67–68 ꢀC); Rf 0.45 (1:19
ethyl acetate/hexanes); FTIR (neat) 3090, 2923, 2358, 1525, 1483,
1451, 1341, 1206, 727, 677 cmꢁ1 1H NMR (400 MHz, CDCl3)
; d 6.68
4.9. 1-(4-Methoxyphenyl)-1H-indole (Table 3, entry 8)3b
(d, J¼2.8 Hz, 1H), 7.13–7.23 (m, 2H), 7.29 (d, J¼3.6 Hz, 1H), 7.49–7.52
(m, 1H), 7.63 (t, J¼8.0 Hz, 2H), 7.78–7.81 (m, 1H), 8.11–8.13 (m, 1H),
White solid, mp 57–59 ꢀC (lit.16 59.5–60.5 ꢀC); Rf 0.68 (1:19 ethyl
8.31–8.32 (m, 1H); 13C NMR (100 MHz, CDCl3)
d 105.5, 110.1, 118.9,
acetate/hexanes); FTIR (neat) 3051, 2924, 2838, 1511, 1456, 1289,
121.0, 121.4, 121.7, 123.4, 127.4, 129.7, 129.8, 130.7, 135.6, 141.1, 149.3;
MS (EI, m/z) 239 [MH]þ; HRMS [MH]þ calculated for C14H10N2O2
239.0821, found 239.0824.
1241, 1027, 833, 734 cmꢁ1; 1H NMR (400 MHz, CDCl3)
d 3.79 (s, 3H),
6.57 (d, J¼3.1 Hz, 1H), 6.93–6.96 (m, 2H), 7.05–7.14 (m, 2H), 7.19 (d,
J¼3.2 Hz, 1H), 7.30–7.34 (m, 2H), 7.37 (d, J¼8.2 Hz, 1H), 7.60 (d,
J¼7.8 Hz, 1H); 13C NMR (100 MHz, CDCl3)
d
55.7, 103.0, 110.5, 114.9,
4.15. 1-(4-(5-Bromo-1H-indol-1-yl)phenyl)-ethanone
(Table 3, entry 14)
120.2, 121.2, 122.3, 126.2, 128.4, 129.1, 133.1, 136.6, 158.5; MS (EI,
m/z) 224 [MH]þ; HRMS [MH]þ calculated for C15H14NO 224.1075,
found 224.1079.
Pale brown solid, mp 112–114 ꢀC; Rf 0.42 (1:9 ethyl acetate/
hexanes); FTIR (neat) 3108, 2922, 1678, 1599, 1517, 1449, 1266, 841,
4.10. 1-(3-Methoxyphenyl)-1H-indole (Table 3, entry 9)16
761, 721 cmꢁ1 1H NMR (400 MHz, CDCl3)
; d 2.66 (s, 3H), 6.67 (d,
J¼3.2 Hz,1H), 7.34 (dd, J¼2.0, 8.8 Hz,1H), 7.37 (d, J¼3.6 Hz,1H), 7.49
Colorless liquid; Rf 0.63 (1:19 ethyl acetate/hexanes); FTIR (neat)
(d, J¼8.8 Hz, 1H), 7.58 (d, J¼8.4 Hz, 2H), 7.82 (d, J¼1.6 Hz, 1H), 8.13
3055, 2946, 2835, 1595, 1483, 1458, 1208, 1040, 731, 688 cmꢁ1
;
1H
(d, J¼8.8 Hz, 2H); 13C NMR (100 MHz, CDCl3)
d 26.7, 104.5, 112.1,
NMR (400 MHz, CDCl3)
d
3.77 (s, 3H), 6.59 (d, J¼3.2 Hz, 1H), 6.81
114.3, 123.5, 124.0, 125.9, 128.7, 130.3, 131.6, 134.3, 135.1, 143.4,
196.9; MS (EI, m/z) 314 [MH]þ; HRMS [MH]þ calculated for
C16H13BrNO 314.0181, found 314.0176.
(dd, J¼1.6, 8.4 Hz, 1H), 6.97 (t, J¼2.0 Hz, 1H), 7.01 (d, J¼8.0 Hz, 1H),
7.06–7.15 (m, 2H), 7.25 (d, J¼3.2 Hz, 1H), 7.32 (t, J¼8.0 Hz, 1H), 7.51
(d, J¼8.4 Hz, 1H), 7.59 (d, J¼7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3)
d
55.6,103.7,110.3,110.8,112.1, 116.7,120.5,121.3,122.5,128.0,129.5,
4.16. 1-(4-(5-Methoxy-1H-indol-1-yl)phenyl)-ethanone
(Table 3, entry 15)
130.4, 135.9, 141.1, 160.7; MS (EI, m/z) 224 [MH]þ; HRMS [MH]þ
calculated for C15H14NO 224.1075, found 224.1071.
Colorless solid, mp 99–101 ꢀC; Rf 0.32 (1:9 ethyl acetate/hex-
4.11. 1-(4-(1H-Indol-1-yl)phenyl)-ethanone (Table 3,
anes); FTIR (neat) 3096, 2921, 2852, 1665, 1593, 1509, 1463, 1260,
entry 10)17
1150.0, 840, 805, 758, 725 cmꢁ1 1H NMR (400 MHz, CDCl3)
; d 2.65
(s, 3H), 3.88 (s, 3H), 6.66 (d, J¼3.2 Hz, 1H), 6.91 (dd, J¼2.4, 8.8 Hz,
1H), 7.14 (d, J¼2.4 Hz, 1H), 7.36 (d, J¼3.2 Hz, 1H), 7.54 (d, J¼8.8 Hz,
1H), 7.58–7.61 (m, 2H), 8.09–8.12 (m, 2H); 13C NMR (100 MHz,
White solid 84–86 ꢀC (lit.18 85–87 ꢀC); Rf 0.42 (1:9 ethyl acet-
ate/hexanes); FTIR (neat) 3057, 2922, 1671, 1595, 1512, 1454, 1269,
731 cmꢁ1
;
1H NMR (400 MHz, CDCl3)
d
2.52 (s, 3H), 6.61 (d,
CDCl3) d 26.7, 56.0, 103.3, 105.0, 111.6, 113.0, 123.0, 127.9, 130.2,